ECMO use in COVID-19: lessons from past respiratory virus outbreaks-a narrative review
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Cho, Hwa Jin | - |
dc.contributor.author | Heinsar, Silver | - |
dc.contributor.author | Jeong, In Seok | - |
dc.contributor.author | Shekar, Kiran | - |
dc.contributor.author | Li Bassi, Gianluigi | - |
dc.contributor.author | Jung, Jae Seung | - |
dc.contributor.author | Suen, Jacky Y. | - |
dc.contributor.author | Fraser, John F. | - |
dc.date.accessioned | 2021-08-30T21:25:55Z | - |
dc.date.available | 2021-08-30T21:25:55Z | - |
dc.date.created | 2021-06-19 | - |
dc.date.issued | 2020-06-06 | - |
dc.identifier.issn | 1466-609X | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/55047 | - |
dc.description.abstract | The spread of coronavirus disease 2019 (COVID-19) continues to grow exponentially in most countries, posing an unprecedented burden on the healthcare sector and the world economy. Previous respiratory virus outbreaks, such as severe acute respiratory syndrome (SARS), pandemic H1N1 and Middle East respiratory syndrome (MERS), have provided significant insights into preparation and provision of intensive care support including extracorporeal membrane oxygenation (ECMO). Many patients have already been supported with ECMO during the current COVID-19 pandemic, and it is likely that many more may receive ECMO support, although, at this point, the role of ECMO in COVID-19-related cardiopulmonary failure is unclear. Here, we review the experience with the use of ECMO in the past respiratory virus outbreaks and discuss potential role for ECMO in COVID-19. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | BMC | - |
dc.subject | EXTRACORPOREAL MEMBRANE-OXYGENATION | - |
dc.subject | CRITICALLY-ILL PATIENTS | - |
dc.subject | H1N1 VIRUS | - |
dc.subject | TRANSMISSION DYNAMICS | - |
dc.subject | CORONAVIRUS | - |
dc.subject | INFECTION | - |
dc.subject | PNEUMONIA | - |
dc.subject | FAILURE | - |
dc.subject | MORTALITY | - |
dc.subject | AGENT | - |
dc.title | ECMO use in COVID-19: lessons from past respiratory virus outbreaks-a narrative review | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Jung, Jae Seung | - |
dc.identifier.doi | 10.1186/s13054-020-02979-3 | - |
dc.identifier.scopusid | 2-s2.0-85086296517 | - |
dc.identifier.wosid | 000540582400005 | - |
dc.identifier.bibliographicCitation | CRITICAL CARE, v.24, no.1 | - |
dc.relation.isPartOf | CRITICAL CARE | - |
dc.citation.title | CRITICAL CARE | - |
dc.citation.volume | 24 | - |
dc.citation.number | 1 | - |
dc.type.rims | ART | - |
dc.type.docType | Review | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | General & Internal Medicine | - |
dc.relation.journalWebOfScienceCategory | Critical Care Medicine | - |
dc.subject.keywordPlus | EXTRACORPOREAL MEMBRANE-OXYGENATION | - |
dc.subject.keywordPlus | CRITICALLY-ILL PATIENTS | - |
dc.subject.keywordPlus | H1N1 VIRUS | - |
dc.subject.keywordPlus | TRANSMISSION DYNAMICS | - |
dc.subject.keywordPlus | CORONAVIRUS | - |
dc.subject.keywordPlus | INFECTION | - |
dc.subject.keywordPlus | PNEUMONIA | - |
dc.subject.keywordPlus | FAILURE | - |
dc.subject.keywordPlus | MORTALITY | - |
dc.subject.keywordPlus | AGENT | - |
dc.subject.keywordAuthor | Coronavirus disease-2019 (COVID-19) | - |
dc.subject.keywordAuthor | Extracorporeal membrane oxygenation (ECMO) | - |
dc.subject.keywordAuthor | Severe acute respiratory syndrome (SARS) | - |
dc.subject.keywordAuthor | Middle East respiratory syndrome (MERS) | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.